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In recent years, there have been an intense interest in the diagnostic
applications of circulating DNA. One source of such interest is in the
rapid adoption of noninvasive prenatal testing (NIPT) using cell-free
fetal DNA in maternal plasma. One area of focus of my laboratory is
to explore the limit of NIPT. In this regard, we have recently com-
pleted a ‘second generation’ noninvasive fetal genome from mater-
nal plasma. For this work, we have sequenced the plasma DNA of a
pregnant woman to a depth of 270X haploid genome coverage. This
represents the deepest that a single plasma DNA sample has been
sequenced to date. Using this approach, together with a novel bio-
informatics pipeline, we are able to deduce, for the first time, fetal
de novo mutations on a genomewide level with a sensitivity of 85%
and a positive predictive value of 74%. We are also able to determine
the maternal inheritance of the fetus with a 90-fold increase in reso-
lution when compared with previous attempts. Finally, we have
shown that plasma DNA molecules have preferred ending sites. Inter-
estingly, fetal-derived and maternal-derived plasma DNA molecules
have different sets of such preferred ending sites. This latter discov-
ery has opened up many new avenues of investigation and has cre-
ated new applications, e.g. for determining the fraction of fetal DNA
without using genetic polymorphisms or DNA methylation markers.
NIPT also serves as a model for developing noninvasive diagnostics
in many other fields, e.g. oncology and transplantation.
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Structural genomic variants form a common type of genetic alteration
underlying human genetic disease and phenotypic variation. Despite
major improvements in genome sequencing technology and data ana-
lysis, the detection of structural variants still poses challenges,
particularly when variants are of high complexity. Emerging long-read
single- molecule sequencing technologies provide new opportunities
for detection of structural variants. We demonstrate sequencing of the
genomes of two patients with congenital abnormalities using the ONT© The Author(s). 2017 Open Access This artic
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bioinformatic pipeline - NanoSV - to efficiently map genomic structural
variants (SVs) from the long-read data. Using NanoSV, we readily de-
tected all de novo rearrangements involving multiple chromosomes ori-
ginating from complex chromothripsis events. Genome-wide
surveillance of SVs, revealed 3,253 (33%) novel variants that were
missed in short-read data of the same sample, the majority of which are
duplications < 200 bp in size. Long sequencing reads enabled efficient
phasing of genetic variations, allowing the construction of genome-
wide maps of phased SVs. We employed read-based phasing to show
that all de novo chromothripsis breakpoints occurred on paternal chro-
mosomes and we resolved the long-range structure of the chromothrip-
sis. Our work demonstrates the value of long-read sequencing for
genetic analyses in life sciences research and clinical diagnostics.
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The modern history of cytogenetics fits into five eras; chromosome
spreading, chromosome banding, chromosome painting, chromo-
some arraying and now chromosome sequencing. T.C. Hsu, the cen-
tenary of whose birth we celebrate, was a pioneer of the first. His
use of hypotonic fluid to spread chromosomes was key to the emer-
gence of human cytogenetics and to the collection of animal karyo-
types published in his Atlas of Mammalian Chromosomes edited
with Kurt Benirschke. Forty-five years later, chromosome sequencing
achieved the ultimate resolution by defining chromosome disease in
terms of base pairs. It relies on sorting and collecting chromosomes
in fluid suspension by flow cytometry and, like chromosome paint-
ing, on DNA amplification of the sorted samples. Chromosome sort-
ing is currently the most precise method used for measuring
chromosome and genome size. Ten thousand cleanly-sorted chromo-
somes provide sufficient DNA for Next Generation sequencing in
both plants and animals. Our collaborations demonstrate the poten-
tial of this approach. For example, sequence from sorted gorilla Y
chromosomes reveal, remarkably, that human and gorilla Ys are simi-
lar and that chimpanzee has lost half the Y genes present in both
the other species. In two species of anole lizards, one with large het-
eromorphic sex chromosomes and the other with small homo-
morphic sex chromosomes, sequence from the ancestral Y
chromosome has been fused with sequence from three microchro-
mosomes to form a large Y chromosome. Sequencing B chromo-
somes in two deer species demonstrate the inclusion of differentle is distributed under the terms of the Creative Commons Attribution 4.0
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branches of evolutionary trees, including trisomies and monosomies, as
well as TP53 mutations in Wilms tumours, CDKN2A deletions in neuro-
blastoma, and CDK4 amplifications in rhabdomyosarcoma. Subclones
were the major arena of genome evolution. We observed four major
trajectories of cancer cell evolution including (1) subclonal variation, (2)
subclone coexistence, (3) subclonal explosions, and (4) clonal sweeps.
These trajectories exhibited a striking correlation to clinical risk groups.
Conclusion
Even in very young patients, cancer is a genetically dynamic disease
over space and time. On the one hand, intratumour diversity is a sig-
nificant source of error in genetic biomarker assessment. On the
other hand, specific evolutionary patterns may be useful as future
clinical predictors.
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Clonal chromosome anomalies are frequently acquired in the bone
marrow (BM) of patients with Shwachman-Diamond syndrome (SDS),
and two are the most frequent: an isochromosome of the long arm of
chromosome 7, i(7)(q10), and an interstitial deletion of the long arm of
chromosome 20, del(20)(q). Patients with SDS have a risk of developing
myelodysplasia (MDS) and/or acute myeloid leukaemia (AML), and the
presence of chromosome changes was studied in relation with this risk.
Starting in 1999 we have monitored the cytogenetic picture of a co-
hort of 92 Italian patients with SDS by all suitable cytogenetic and
molecular methods. Clonal anomalies in BM were present in 41/92
patients. The i(7)(q10) was observed in 16 patients, and the del(20)(q)
in 15, both these changes in four, but in independent clones. So, the
most frequent clonal anomalies were found in 35 patients. Other, dif-
ferent, clonal anomalies were found in the BM of 13 patients, in eight
cases in the absence of i(7)(q10) or del(20)(q), in five cases in associ-
ation with one of these changes. In these less common clonal anom-
alies, the distribution of the chromosomes involved was markedly
disparate, and some of them were novel and recurrent:
– structural rearrangements of chromosome 7, mainly
unbalanced (deletions, inversions or translocations), were
present in five of our 13 patients, three of whom developed
MDS/AML.
– a further complex rearrangement of the more common
del(20)(q), leading to duplicated and deleted portions, was
identical in two patients, with almost identical a-CGH profiles,
neither developed MDS/AML.
– an unbalanced translocation t(3;6), with partial trisomy of the
long arm of chromosome 3 and partial monosomy of the long
arm of chromosome 6, was not identical but very similar in two
patients, one of whom developed MDS/AML.
O10
Deletion 13q characterised by SNP microarray profiling of a large
cohort of CLL patients
Nicole Chia 1, Dr Melody Caramins 2
1Qml Pathology, Genetics, Murrarrie, Australia; 2Sds Pathology, Genomic
Diagnostics, Sydney, Australia
Correspondence: Nicole Chia
Molecular Cytogenetics 2017, 10(Suppl 1):O10
The investigation of Chronic Lymphocytic Leukemia (CLL) by con-
ventional cytogenetic analysis combined with fluorescence in-situhybridisation (FISH) has been regarded as the gold standard. De-
tection and characterisation of non-random rearrangements is
hindered in part by the limitation of cell culturing and the tar-
geted approach of FISH testing. More recently the implementa-
tion of molecular karyotyping by high resolution Single
Nucleotide Polymorphism (SNP) microarray platforms has aug-
mented the investigation protocol of haematological malignancies
in diagnostic pathology.
Deletion 13q is reported in up to 50% of patients with CLL and has
historically been reported in association with low risk disease. Mo-
lecular karyotyping has revealed the diversity and complexity of rear-
rangements within the del13q region. This has culminated in the
classification of the 13q deletion into type I (exclusive of Rb1) and
type II (inclusive of Rb1). However uncertainty exists with regard to
the prognostic significance, particularly with respect to the large,
type II deletion.
To evaluate this we investigated the molecular karyotype of 500 CLL
patients. We ascertained the incidence of del13q type I and type II,
complexity of deletions, association with additional karyotypic
changes and cnLOH chromosome 13. Our results show that there is
no significant difference in the incidence or association with add-
itional karyotypic changes, but type II deletion is associated with
complex 13q deletions (p = 0.0001). Furthermore there is no signifi-
cant difference with respect to cytogenetic progression in follow-up
testing of 43 patients. This study highlights the benefit of SNP micro-
array analysis in characterising deletion anatomy and the need for
re-evaluation of risk stratification of non-random rearrangements.
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Genome amplification, in the form of homogeneously staining regions,
double minutes, and ring/giant rod-shaped markers, is a pivotal event
in many tumors. It was recently shown that amplifications as extra-
chromosomal DNA are present in nearly half of all tumors, representing
a driving force towards their accelerated evolution. To achieve a better
understanding of the implications of genomic amplifications we fo-
cused on their structure and impact upon transcription. Amplified
cancer-associated genes are often overexpressed as a direct conse-
quence of the copy number gain. We analyzed the whole genome
(WGS) and transcriptome (RNA-seq) sequencing data of nine small cell
lung carcinoma (SCLC), seven neuroblastoma (NB) and three well-
differentiated liposarcoma (WDLPS) cell lines, all carrying genomic am-
plifications. A widespread heterogeneity of the amplicon arrangement
was detected in most of the samples, disclosing the progressive evolu-
tion of their structure through cell divisions. By integrating the WGS
(structural variation calling) and RNA-seq (chimeric transcripts detec-
tion) data, we detected a burst of chimeras derived from post-
transcriptional events (i.e. cis- or trans-splicing) involving amplified
genes. Notably, we found PVT1 (8q24) and RLF (1p34.2) as hot-
spots for cis- or trans-splicing events in SCLC and NB samples
with MYC and MYCL1 amplifications, respectively. In WDLPS cell
lines, we found extremely complex fusion genes, such as those
involving three partners or assembled by multiple interposed
non-contiguous, non-collinear genomic fragments (spliced out in
the mature transcript). Our results strongly indicate that the
“amplification/overexpression” paradigm does not cover all as-
pects of the genomic amplification impact upon transcription.
The extraordinary transcriptome plasticity herein described,
enriching the genetic repertoire of cancer cells with genomic am-
plifications, likely provides a selective advantage and might have
a crucial role in cancer establishment and progression.
